Skip to main content

Table 3 Characteristics of fasting1 versus non-fasting participants by sex, the HUNT 2 study

From: Age-specific prevalence of the metabolic syndrome defined by the International Diabetes Federation and the National Cholesterol Education Program: the Norwegian HUNT 2 study

  Men Women
  Fasting1 Non fasting   Fasting1 Non fasting  
N (%) 5101
(17.0%)
24,914
(83.0%)
  5105
(15.2%)
28,480
(84.8%)
 
Categorical measures, % (95% CI)    Odds ratio    Odds ratio
IDF-proxy for metabolic syndrome2 13.8
(12.8–14.7)
14.4
(14.0–14.9)
1.05
(0.97–1.15)
14.8
(13.9–15.8)
13.8
(13.4–14.2)
0.92
(0.85–1.00)
ATP-proxy for metabolic syndrome3 5.8
(5.2–6.5)
5.8
(5.5–6.1)
1.00
(0.88–1.14)
9.8
(8.9–10.6)
9.0
(8.7–9.4)
0.92
(0.83–1.02)
Type 2 diabetes 1.6
(1.2–1.9)
1.9
(1.7–2.0)
1.18
(0.93–1.49)
2.0
(1.6–2.4)
1.6
(1.5–1.8)
0.81
(0.65–1.01)
Antihypertensive medication 10.3
(9.5–11.1)
10.3
(9.9–10.6)
1.00
(0.90–1.10)
13.1
(12.2–14.0)
11.6
(11.2–12.0)
0.87*
(0.80–0.96)
Continuous measures, means (95% CI)    Mean z-score diff.    Mean z-score diff.
Age, y 48.4
(48.0–48.9)
50.0
(49.8–50.2)
0.093* 49.4
(48.9–49.8)
50.2
(50.0–50.4)
0.048*
Systolic blood pressure, mm Hg 140.4
(139.8–140.9)
140.0
(139.7–140.2)
-0.022 137.3
(136.6–137.9)
135.8
(135.5–136.1)
-0.062*
Diastolic blood pressure, mm Hg 83.4
(83.0–83.7)
81.7
(81.6–81.9)
-0.138* 80.0
(79.6–80.3)
78.7
(78.6–78.9)
-0.101*
Waist circumference, cm 92.2
(91.9–92.5)
91.9
(91.8–92.0)
-0.028 82.0
(81.7–82.4)
81.5
(81.4–81.6)
-0.050*
HDL cholesterol, mmol/L 1.26
(1.25–1.27)
1.24
(1.23–1.24)
-0.063* 1.50
(1.49–1.52)
1.49
(1.49–1.50)
-0.029
Triglycerides, mmol/L 1.73
(1.70–1.76)
2.02
(2.01–2.04)
0.240* 1.44
(1.42–1.47)
1.59
(1.58–1.60)
0.153*
Glucose, mmol/L 5.30
(5.27–5.33)
5.60
(5.58–5.62)
0.185* 5.20
(5.17–5.23)
5.41
(5.40–5.43)
0.150*
  1. HUNT, the Nord-Trøndelag Health study; CI, confidence interval; IDF, the International Diabetes Federation; ATP, the National Cholesterol Education
  2. Program-Adult Treatment Panel III; HDL, high-density lipoprotein.
  3. *P < 0.05.
  4. 1Four to nine hours or more since the last meal.
  5. 2IDF-proxy for metabolic syndrome defined as IDF-central obesity plus any two of three components (low HDL cholesterol, high blood pressure or treatment for previously diagnosed hypertension, or previously diagnosed type 2 diabetes).
  6. 3ATP-proxy for metabolic syndrome defined as any three of four components (ATP III-defined central obesity, low HDL cholesterol, high blood pressure or treatment for previously diagnosed hypertension, or previously diagnosed type 2 diabetes).